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Abstract
Background: Coccidioidomycosis is a fungal infection that usually presents as a primary lung infection. The fungus
is endemic to the Southwest United States of America, northern Mexico and parts of Central and South America
the infection is rare outside these areas. However, some patients develop disseminated infection that can lie dormant
for several years and can present itself in travelers. We report the first case of extra pulmonary Coccidioidomycosis in a
non-immunocompromised individual in Denmark.
Case presentation: A 32 year old Danish woman presented at the Emergency department with abdominal pain.
Computed tomography scan and ultrasound examination of the pelvis raised suspicion of salpingitis. A laparoscopy
exposed a necrotic salpinx and several small white elements that resembled peritoneal carcinomatosis. Histological
workup however determined that she suffered from disseminated coccidioidomycosis. The patient had lived 2 years in
Las Vegas, in the United States of America, 7 years prior and had no memory of lung infection at the time.
Conclusions: Disseminated coccidioidomycosis is rare in non-immunocompromised individuals. The patient in this
case underwent several rounds of in vitro fertilization treatment in the years before admittance. We suspect that the
hormonal treatment in combination with low-dose prednisolone may have triggered reemergence of the disease and
present literature that support this.
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Background
Coccidioidomycosis (CM) is a fungal infection caused by
infection by either Coccidioides immitis or C. posadasii.
The two species are closely related and morphologically
identical [1]. The fungi are endemic to the arid desert
areas of the southwest United States of America (USA)
and northern Mexico, but can also occasionally be found
in other desert areas in South America. The fungi are
dimorphic, with the mycelial (mold) stage growing in
dry soil. During growth the mycelium breaks down into
separate arthroconidia, which are very small (5 × 4 um)
and easily carried away on dust particles. When inhaled
the tiny arthroconidia reach the alveoli where they de-
velop into the endospore (parasitic) stage. This causes a
primary lung infection that in most cases is self-limiting.
In 5% of patients the primary infection may be followed
by the development of pulmonary nodules, cavities, or
progressive pulmonary disease. In rare cases patients
may develop progressive disseminated disease at the
time of initial presentation or years later, presumably as
a result of reactivation of latent infection. Disseminated
disease is seen in up to 1% of cases and often in immuno-
compromised individuals and those of African American
or Filipino descent. The spread is hematogenous and the
most common sites of secondary infection are the menin-
ges, skin, joints and bones. Disseminated disease is associ-
ated with a poor prognosis, high mortality and may
require lifelong anti-fungal treatment [2, 3].
The diagnosis is based on histopathological demon-
stration of fungal structures, culture (Biosafety level 3),
skin tests, demonstration of humoral antibodies (with
commercially available methods of enzyme immune
assay (EIA) and immunodiffusion (available for both
early IgM and late IgG) and complement fixation (IgG),
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a quantitative antigen detection EIA and newer molecu-
lar methods such as polymerase chain reaction for cocci-
dioidal DNA [2, 3].
Localized extra-pulmonary infection also occurs in
immuno-competent individuals. We report an unusual
presentation of CM in a young Danish woman diag-
nosed after being admitted to hospital for acute abdom-
inal pain.
Case presentation
A 32-year-old Caucasian female presented to the emer-
gency department in 2015 complaining of abdominal
pain, with acute onset 8 h prior. The pain was constant,
localized in the right lower quadrant and intensity was
rated as 8–9 on the visual analogue scale. Routine
biochemistry including leukocyte count and C-reactive
protein was normal.
A computed tomography (CT) scan of the abdomen re-
vealed fluid in the peritoneum and possible cysts on the
right ovary. A gynecological examination was normal,
aside from tenderness behind the uterus. A transvaginal
ultrasound showed free fluid in the Pouch of Douglass
and a 5x4x6 cm large mass between the right ovary and
the uterus. At this point the pain had improved consider-
ably on pain medication and the patient was scheduled for
an explorative laparoscopy 4 days later.
The laparoscopy found a dilated, necrotic and torqued
right salpinx, congealed blood in the Pouch of Douglass
and several 1–2 mm, white, round elements on both the
salpinx and on all peritoneal surfaces. The right salpinx
and several of the peritoneal elements were sent for
histological examination alone. Due to the macroscopic
appearance, peritoneal carcinomatosis was suspected, al-
though CT scan and laparoscopy had not exposed any
underlying malignancies.
However, histological examination revealed no signs of
malignancy, but a dilated salpinx with fungal structures,
widespread necrosis and severe inflammation with numer-
ous eosinophilic granulocytes and vasculitis like changes
in the sub serosal vessels. The peritoneal biopsies showed
small thrombotic vessels with fungal structures, within the
thrombotic material (Fig. 1). The pathologist suspected
blastomycosis or another dimorphic fungus. The final
histopathological diagnosis of CM was made by identi-
fication of the typical large (10–100 μm) endospore-
containing spherulae [4] after consulting Danish (Statens
Serum Institut) and American microbiologists (Indiana
Health Pathology, Indiana University Medical Center,
Indianapolis, Indiana, USA) (Fig. 2). No unfixed tissue
samples were available for culture or molecular identifica-
tion methods.
The patient was referred to the department of infec-
tious diseases where further history taking revealed that
the patient had lived in Las Vegas, Nevada from 2006 to
2008 and revisited in 2009 and 2011. In the last 5 years
she has also visited Argentina, Guatemala, Nigeria,
Zambia and South Africa. She could not recall any epi-
sodes of illness while traveling. The diagnosis was con-
firmed by serology [5, 6] (immunodiffusion (Meridian
Bioscence, OH, USA)) demonstrating IgG antibodies
against Coccidioides, with an antibody titer of 1:8. Fur-
ther workup with a CT-scan of the thorax showed a
16 mm large calcified process in the apex of the right
lung. There were no signs of immune deficiency with a
negative HIV-test, normal levels of immunoglobulins
and a normal CD4 cell count of 1020 cells/μL. Her med-
ical history was inconspicuous; the only prior hospital
contact was for fertility treatment that did not result in
pregnancy. One to 3 years prior to admittance she
underwent four separate in vitro fertilization (IVF) treat-
ments. For the last two rounds of IVF she was also
treated with a low dose of prednisolone, 10 mg daily. In
Fig. 1 Peritoneal biopsy showing a small occluded vessel with a
spherule (original magnification × 100, HE-stain)
Fig. 2 30 μm large endospore-containing spherule, floating in
necrotic debris (original magnification × 630, AV-stain)
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2012, three days after the first insemination, the patient
was admitted to the ED for abdominal pain, was ob-
served for 24 h and discharged without further workup.
The patient was started on treatment with oral flucon-
azole 400 mg twice daily for 1 week, followed by 400 mg
once daily. Treatment was scheduled for at least
6 months and possibly longer guided by serological re-
sponse. Three months and 6 months after initiation of
treatment the patient’s antibody titer had fallen to 1:2
and 1:1 respectively. The patient completed 8 months of
fluconazole treatment, with a reduced dose of 200 mg
daily for the last month. Two months after completion
of therapy the antibody titer was still 1:1. To ensure that
the pelvic and peritoneal CM had resolved a laparoscopy
was done three and a half month after completion of
therapy. The laparoscopy found a dilated, chronic in-
flamed left salpinx and persistence of the small 1–2 mm,
white, round elements on the peritoneal surfaces. The
histological examination confirmed granulomatous infec-
tion with numerous coccidioidal spherules. The patient was
immediately restarted on treatment with oral fluconazole
400 mg twice daily. At the moment, length of treatment
has not been decided and other treatment options, such as
liposomal amphotericin-B or voriconazole, are being con-
sidered. The timeline for the case is summerized in (Fig. 3).
Discussion
The peritoneum and genital tract are rare sites of extra
pulmonary CM. A review from 2015 identified 34 case
reports of peritoneal involvement, mostly male (76%)
living in endemic areas [7]. As for genital involvement, a
review from 1999 found 13 cases of either tubo-ovarian
or endometrial disease [8]. The patient in our case
showed no signs of systemic disease. Other cases have
been reported where patients have localized extra pul-
monary CM without systemic disease [9–11]. It is prob-
able that the patient had a primary lung infection while
living in the USA that was either asymptomatic or that
she could not recall. The process found in the lung could
be a remnant of this. The diagnosis of this clinical case
was done by histopathological identification of typical
spherules, thus we cannot determine whether the infec-
tion was caused by Coccidioides immitis or Coccidioides
posadasii. The diagnosis was not confirmed by culture or
by molecular methods. However, it is recognized that the
diagnosis of disseminated coccidioidomycosis can rely on
the histopathologic identification of fungal structures in a
sample from an extrapulmonary lesion [3], further the
diagnosis was corroborated serologically and consistent
with the patient’s travel history.
The initial treatment course was for 8 months. But
despite the clinical well-being of the patient and a
marked serological response, the laparoscopy revealed
persistent peritoneal infection and that the coccidioidal
infection had spread to the left salpinx. We cannot de-
termine whether the coccidioidal infection had never
been cleared or whether the infection had relapsed when
fluconazole was discontinued. The Infectious Diseases
Socieaty of America (IDSA) guidelines recommend at
least 6–12 months of treatment for extrapulmonal soft
tissue infection [3] and our case emphasizes the import-
ance of long-term treatment.
In our case, the peritoneal plaques were initially sus-
pected to represent peritoneal carcinomatosis. In two
previously published cases, female genital coccidioido-
mycosis mimicked ovarian cancer due to the presence of
an ovarian mass in combination with elevated levels of
the tumor-markers CA125 and CA 19–9 [12, 13] and
malignant-appearing nodules on all serosal surfaces of
the peritoneum [13]. Pregnancy is a known major risk
factor for disseminated disease. The reasons are thought
to be a combination of the mild immune suppression
that occurs during pregnancy, combined with the fact
that sex-hormones seems to aid dissemination [14].
Especially high levels of progesterone and 17β-estradiol
have been shown to stimulate growth of C. immitis in
vitro [15].
The patient in our case was not immunocompromised
or pregnant. As mentioned, she did however, undergo four
separate IVF treatments 1–3 years before admittance.
Fig. 3 Timeline of case report
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Prior to each treatment the patient was given clomiphene
to initiate controlled ovarian stimulation, during which es-
tradiol levels rise. It is possible that the IVF treatments,
perhaps in combination with mild immunosuppression
caused by the concurrent prednisolone treatment, could
have triggered dormant stages of the disease and that dis-
semination may possibly have happened as far back as
2012. We have not been able to identify other cases in the
literature where IVF has been associated with CM. It is
also possible that a latent chronic coccidioidal salpingitis
could be the primary cause of the patient’s infertility. A
long history of infertility has also been reported in other
women diagnosed with genital CM [16].
Conclusion
Imported CM is a rare condition in Denmark, with only
one case diagnosed approximately every 10 years [17, 18].
This is the first reported case of extra pulmonary CM, in-
volving the peritoneum and genital tract, in an otherwise
healthy individual in Denmark. The case shows that
physicians outside endemic areas have to be aware of this
disease that can reemerge several years after exposure.
The case history also reveals a possible connection with
prior IVF treatment, which could have triggered latent
chronic infection. This has to our knowledge not been re-
ported anywhere else.
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